Needle-free injector market expected to reach $42.79

Label Market Accelerates at 4.8% CAGR to Catch US Dollar


NEWARK, Del, Sept. 16, 2022 (GLOBE NEWSWIRE) — A study recently published by the FMI expects the global needle-free injector market to grow at a CAGR of 12% between 2022 and 2032. At the end of that period of evaluation, a valuation of US$ 42.79 billion is expected for the market. Faster drug delivery is the key driver for the needle-free injector market. Increasing demand from the healthcare sector coupled with the growth in cosmetic surgeries is driving the demand for needle-free injectors.

From 2017 to 2021, the industry saw remarkable growth, posting a CAGR of 8% and closing at $12.3 billion. The use of technologically advanced spring-loaded jet injectors is driving market growth. Additionally, approvals from government authorities to maximize the use of needle-free injectors is accelerating demand for them.

Request sample @

Geographically, the US is the largest contributor to the needleless injector market. This is due to the increasing prevalence of chronic diseases in the region. The strong presence of the health sectors in Germany, Japan and China is also accelerating the use of needle-free injectors. In the coming years, the growing trend towards minimally invasive surgeries will boost sales of needle-free injectors.

Key takeaways from the market study

  • By payload type, the projectile injection segment is expected to expand at a rate CAGR of 13.9% during the forecast period.
  • By technology, the segment of spring-loaded jet injectors will dominate the market, keeping 47.1% of revenue share in 2022.
  • By application, drug delivery is expected to hold the leading market share, accounting for 65.0% of revenue share in 2022.
  • With 79.5% of revenue share, reusable needle-free injectors expected to dominate market in 2022
  • By end user, hospitals are expected to be the primary end user, representing more than 33.4% market share during the forecast period.
  • The US is expected to be a leading market in North America, accounting for more than 94.0% of the market in 2022
  • Germany is expected to dominate Europe, keeping 29.4% Europe market share until 2032
  • Japan is expected to hold more than 34% East Asian market share, exhibiting growth at a CAGR of 11.7% during the forecast period
  • China led the East Asian market with more than 46.8% share and is projected to expand at a CAGR of 12.0% until 2032.

“The health sector along with the cosmetics industry are the largest contributors to the needle-free injector market. The growing demand for minimally invasive surgeries is further accelerating the demand for needle-free injectors.” says an IMF analyst

Speak to Analyst @

market competition

Major players in the needle-free injector market are Gerresheimer AG, Pfizer Inc., Antares Pharma, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation

  • In August 2022, the University of Adelaide began the human trail of the omicron COVID vaccine booster using Pharma-Jet needle-free systems. Additionally, vaccines have been administered using PharmaJet Tropis NFIS.
  • Portal Instruments, a key player in the needle-free injector market, is focusing on developing needle-free injectors for different chronic ailments and raising awareness of pain-free injections.

More information available

FMI, in its new offering, presents an unbiased analysis of the global needle-free injector market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period 2022-2032.

The study reveals essential information on the basis of payload (liquid injections, powder injections, projectile injections), technology (spring loaded jet injector, battery powered jet injector, gas powered jet injector), location of administration (intradermal injectors, intramuscular injectors). injectors, subcutaneous injectors), application (drug delivery, vaccines, cosmetics, others), end-user (home care settings and long-term care facilities) in seven major regions (North America, Latin America, Europe, East Asia , South Asia, Oceania, and the Middle East and Africa)

Use promo code ->> FMITODAY to get flat 20% discount

About the healthcare domain in Future Market Insights

Future Market Insights’ healthcare domain team delivers expert analysis, time-efficient research, and strategic recommendations with the goal of providing authentic information and accurate results to help clients around the world. With a repertoire of over 100 reports and over 1 million data points, the team has been insightfully analyzing the industry in over 50 countries for over a decade. The team provides a brief analysis of key trends, including the competitive landscape, profit margin, and research development efforts.

Table of Contents
1. Executive Summary

1.1. World Market Outlook

1.2. Demand-side and supply-side trends

1.3. technology roadmap

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

23. Inclusions and Exclusions

3. Key market trends

3.1. Key trends affecting the market

3.2. Product Innovation / Development Trends

Get detailed TOC @

Take a look at research reports related to health care

Contrast Media Injector Market Size: The global contrast media injector market was valued at $1.4 billion in 2021 and is expected to reach $2.4 billion by 2030, according to Future Market Insights (FMI) in a recent report. recent market survey.

Growth of the needle-free vaccine injectors market: The growth in the number of communicable diseases due to needlestick injuries is one of the main factors driving the growth of the market.

Portable Injector Market Technology – Portable injectors are drug delivery devices created for single-use portable device technologies that are designed to deliver large volumes of medication to patients over extended periods of time.

Functional Electrical Stimulation Market Analysis: The global functional electrical stimulation market is anticipated to be worth US$600 million in 2022, forecast a CAGR of 4.1% valued at US$897 million from 2022 to 2032.

Gastrointestinal Rare Disease Treatment Market Forecast: The global gastrointestinal rare disease treatment market garnered a market value of US$1,314.8 million in 2022 and is expected to accumulate a market value of US$1,965 million by registering a CAGR of 3.7% in the forecast period 2022 -2032.

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR certified business consulting and market research firm, a member of the Greater New York Chamber of Commerce and is based in Delaware, USA. We received the 2022 Clutch Leaders Award due to the high customer score (4.9/5), we have been collaborating with global companies on their business transformation journey and helping them fulfill their business ambitions. 80% of the largest Forbes 1000 companies are our clients. We serve global clients in all leading and niche market segments in all major industries.


Future Market Insights, Inc.
Christiana Corporation, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705


Source link